X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs IPCA LABS - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD IPCA LABS ALEMBIC LTD/
IPCA LABS
 
P/E (TTM) x 53.4 30.6 174.3% View Chart
P/BV x 2.2 4.5 48.0% View Chart
Dividend Yield % 0.5 0.1 452.4%  

Financials

 ALEMBIC LTD   IPCA LABS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
IPCA LABS
Mar-18
ALEMBIC LTD/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs72695 10.4%   
Low Rs34400 8.5%   
Sales per share (Unadj.) Rs4.7260.2 1.8%  
Earnings per share (Unadj.) Rs6.119.0 32.2%  
Cash flow per share (Unadj.) Rs6.233.1 18.9%  
Dividends per share (Unadj.) Rs0.201.00 20.0%  
Dividend yield (eoy) %0.40.2 206.9%  
Book value per share (Unadj.) Rs40.7213.0 19.1%  
Shares outstanding (eoy) m267.03126.20 211.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.1 535.1%   
Avg P/E ratio x8.728.9 30.0%  
P/CF ratio (eoy) x8.516.6 51.2%  
Price / Book Value ratio x1.32.6 50.7%  
Dividend payout %3.35.3 62.2%   
Avg Mkt Cap Rs m14,13969,120 20.5%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m2077,359 2.8%   
Avg. sales/employee Rs ThNM2,477.4-  
Avg. wages/employee Rs ThNM555.2-  
Avg. net profit/employee Rs ThNM180.6-  
INCOME DATA
Net Sales Rs m1,25532,836 3.8%  
Other income Rs m370418 88.6%   
Total revenues Rs m1,62533,254 4.9%   
Gross profit Rs m1114,505 2.5%  
Depreciation Rs m381,777 2.1%   
Interest Rs m2240 0.7%   
Profit before tax Rs m4422,905 15.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24511 4.7%   
Profit after tax Rs m1,6302,394 68.1%  
Gross profit margin %8.913.7 64.5%  
Effective tax rate %5.417.6 30.8%   
Net profit margin %129.87.3 1,780.8%  
BALANCE SHEET DATA
Current assets Rs m1,86719,455 9.6%   
Current liabilities Rs m59110,076 5.9%   
Net working cap to sales %101.628.6 355.9%  
Current ratio x3.21.9 163.6%  
Inventory Days Days9498 96.3%  
Debtors Days Days7467 109.8%  
Net fixed assets Rs m1,79120,260 8.8%   
Share capital Rs m534252 211.6%   
"Free" reserves Rs m10,32426,633 38.8%   
Net worth Rs m10,85826,886 40.4%   
Long term debt Rs m412,340 1.8%   
Total assets Rs m11,59141,173 28.2%  
Interest coverage x260.913.1 1,992.2%   
Debt to equity ratio x00.1 4.4%  
Sales to assets ratio x0.10.8 13.6%   
Return on assets %14.16.4 220.0%  
Return on equity %15.08.9 168.6%  
Return on capital %15.210.8 141.1%  
Exports to sales %1.547.6 3.2%   
Imports to sales %21.014.9 141.1%   
Exports (fob) Rs m1915,642 0.1%   
Imports (cif) Rs m2634,884 5.4%   
Fx inflow Rs m1915,642 0.1%   
Fx outflow Rs m2644,884 5.4%   
Net fx Rs m-24410,759 -2.3%   
CASH FLOW
From Operations Rs m2363,411 6.9%  
From Investments Rs m-224-1,354 16.5%  
From Financial Activity Rs m-27-1,304 2.0%  
Net Cashflow Rs m-15753 -2.0%  

Share Holding

Indian Promoters % 64.0 45.9 139.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 11.4 1.8%  
FIIs % 9.7 25.3 38.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.4 150.0%  
Shareholders   54,701 36,892 148.3%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 495 Points, Jet Airways in Focus and Other Top Stocks in Action Today(Pre-Open)

On Monday, share markets in India opened on a negative note and ended the day deep in red after a volatile day of trading.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Apr 22, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS